A little over a month ago, I was scheduled to testify before the House and Senate Safe Food Caucuses in DC. Instead, the night before I had a heart attack. are you okay. I received great treatment at Howard University Hospital and made a full recovery. However, I did change some habits going forward.
I was asked to share some thoughts on the infant formula industry’s inability to ensure the safety of these important foods. As I sit here this Sunday afternoon, I wonder how we can spend countless amounts of money on yet another unnecessary war, and even more money on AI and robots that will render most of us useless and do nothing to make baby food safer. Here’s what I wanted to discuss: I’m sure there are other ideas. I’d like to hear them.
Infant formula until recently was considered low risk for: C. botulinum (And there are other pathogens too – Chronobacter Sakazaki, salmonella And recently, bacillus cereus apprehension).
recent C. botulinum The mixed picture we get from looking at NCBI’s large number of WGS sequences suggests that infant formula may be more risky. We need new risk assessments C. botulinum (and other pathogens) How to control pathogens in infant formula and its components and powdered infant formula (PIF). for C. botulinum I need additional information about:
How often are infant formula and its ingredients contaminated? C. botulinum spore?
Do you detect pathogens when you need them? Should we evaluate whether our current methods are good enough (sensitive enough)?
How often is a product contaminated with more than one strain? C. botulinum (multiple WGS profiles)? How many isolates (colonies on a plate) from each sample must be sequenced to detect all contaminants?
Should infant formula be cultured regularly in case of infant botulism when the child is fed such products? (I suspect that infant formula is causing more cases of infant botulism than we currently know.)
How can we best control it? C. botulinum Spores in infant formula. Research is needed on how to control it C. botulinumMore efficiently in infant formula.
Are new regulations and redefined best practices needed for infant formula production and the detection and cultivation of organisms in products, the environment, and patients?
Perhaps as a start:
Fund risk assessments for the spread of: C. botulinum spore, Chronobacter Sakazaki, Salmonella and Bacillus cereus and sulfite-reducing Clostridium (indicator):
no way. crude oil
rain. pasteurized milk
aspirate. Dairy powders – Includes whole milk, whey powder, whey protein concentrate, whey protein hydrolysate, nonfat dry milk, and skim milk powder.
Specific risk assessment for the prevalence of: C. botulinum Reduces spores and sulfites clostridium Powdered infant formula
Risk assessment for prevalence C. botulinum Spores in minimally processed (non-retort heat processed) commercial baby foods fed to children under 1 year of age.
Risk assessment for prevalence C. botulinum Spores from low-hydration infants’ first foods (puffs, cereals (rice and oatmeal), peanut butter, etc.)
Processing strategies to minimize spores in PIF – Investigating technologies to reduce spores in infant foods while maintaining nutritional standards
Impact of agricultural practices on incidence C. botulinum spores in milk
no way. penetration rate C. botulinum Spores on farm silage, bedding, etc.
rain. Milk collection from organic and conventional dairy farms
Improved resources for infant tracking and follow-up botulism If you check the source botulism attack
The key to spore control in powdered infant formula (PIF) is to destroy all spores or reconstitute them to reduce the spore rate in the PIF (at least to the level prior to adding whole milk powder to the PIF formulation). Since PIF is supplied to infants from day 1, it must be commercially sterilized. Leave it to the company to decide how to commercially sterilize PIF. At least I’d like to suggest something like this: C. botulinum If spores are present in whole milk powder and a risk assessment has been performed, preparations containing whole milk powder should not be placed on the market.
